SUSANA
BARRENA DELFA
Investigadora
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (12)
2021
2018
-
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy
Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331
2014
-
Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene
American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294
2011
-
Flow cytometry immunophenotyping of fine-needle aspiration specimens: Utility in the diagnosis and classification of non-Hodgkin lymphomas
Histopathology, Vol. 58, Núm. 6, pp. 906-918
2010
-
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: A step forward in the standardization of clinical immunophenotyping
Leukemia, Vol. 24, Núm. 11, pp. 1927-1933
-
Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on A series of 56 patients
Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. 3, pp. 154-168
-
Monoclonal free light chains can be found in heavy chain diseases
Annals of Clinical Biochemistry, Vol. 47, Núm. 6, pp. 570-572
2008
-
Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: Analysis of a series of 432 patients
Blood, Vol. 111, Núm. 10, pp. 5130-5141
-
Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia
Cytometry Part B - Clinical Cytometry, Vol. 74, Núm. 3, pp. 139-149
-
The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors
Leukemia, Vol. 22, Núm. 6, pp. 1175-1183
2005
-
Intrinsically fluorescent cytotoxic cisplatin analogues as DNA marker molecules
Bioconjugate Chemistry, Vol. 16, Núm. 2, pp. 275-282
2004
-
CD34 + cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance - Associated phenotypes
Clinical Cancer Research, Vol. 10, Núm. 22, pp. 7599-7606